News & Updates

In a study presented at EASL 2025, the use of statins appears to be associated with a reduced risk of hepatocellular carcinoma (HCC) and slower progression of liver fibrosis in individuals with chronic liver disease (CLD).

Fatigue is more frequently reported in paediatric patients with inflammatory bowel disease (IBD) compared with controls and is associated with anaemia in a nationwide study.

A network meta-analysis (NMA) reports that the combination regimen comprising atezolizumab and bevacizumab appears to be better than other first-line systemic therapeutic alternatives for advanced hepatocellular carcinoma (HCC) in terms of providing a balance between overall survival (OS) benefit and quality of life (QoL) preservation.

As cliché as it sounds, adopting a healthy lifestyle helps prevent the development of colorectal cancer (CRC). A recent study has shown that adhering to well-balanced diet, maintaining a normal weight, staying physically active, and avoiding tobacco and alcohol all contribute to a reduction in CRC risk.